Company Overview of Reliance GeneMedix Limited
Reliance GeneMedix Limited, together with its subsidiaries, develops, manufactures, and distributes biotechnology pharmaceuticals. The company’s biosimilars are a generic version of recombinant therapeutic proteins. Its product under development includes EPOSTIM, a erythropoietin alpha that is used as a support therapy for the treatment of acute, chronic, and end-stage renal failure; in cancer-induced and chemotherapy related anemia; in patients undergoing major surgeries; and in AIDS patients on zidovudine treatment. The company is headquartered in Tullamore, Ireland. Reliance GeneMedix Limited is a subsidiary of Reliance Life Sciences Pvt. Ltd.
IDA Business & Technology Park
353 5 793 23572
353 5 793 23592
Key Executives for Reliance GeneMedix Limited
Reliance GeneMedix Limited Key Developments
Similar Private Companies By Industry
|Alexo Therapeutics Ltd||Europe|
|Algae Health Ltd.||Europe|
|Alimentary Health Limited||Europe|
|Artugen Therapeutics Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Reliance GeneMedix Limited, please visit www.genemedix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.